GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Ending Cash Position

DT&CRO Co (XKRX:383930) Ending Cash Position : ₩13,798 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is DT&CRO Co Ending Cash Position?

DT&CRO Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩13,798 Mil.

DT&CRO Co's quarterly Ending Cash Position declined from Sep. 2023 (₩5,183 Mil) to Dec. 2023 (₩5,054 Mil) but then increased from Dec. 2023 (₩5,054 Mil) to Mar. 2024 (₩13,798 Mil).

DT&CRO Co's annual Ending Cash Position increased from Dec. 2021 (₩7,074 Mil) to Dec. 2022 (₩20,501 Mil) but then declined from Dec. 2022 (₩20,501 Mil) to Dec. 2023 (₩5,054 Mil).

DT&CRO Co Ending Cash Position Historical Data

The historical data trend for DT&CRO Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DT&CRO Co Ending Cash Position Chart

DT&CRO Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Ending Cash Position
3,939.08 7,074.08 20,500.89 5,054.38

DT&CRO Co Quarterly Data
Jun21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only 14,275.11 8,890.58 5,182.54 5,054.38 13,797.93

DT&CRO Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

DT&CRO Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=20500.886+-15446.511
=5,054

DT&CRO Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=5054.375+8743.552
=13,798

DT&CRO Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of DT&CRO Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

DT&CRO Co (XKRX:383930) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Ending Cash Position
Comparable Companies
XKRX:298060 XKRX:065650 XKRX:299660 XKRX:142760 XKRX:115180 XKRX:032790 XKRX:222110 XKRX:036480 XKRX:456570 XKRX:208340 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
28, Baengnyeong-ro 20beon-gil, 2nd, 3rd, 4th floor, Na-dong, Cheoin-gu, Gyeonggi-do (Yubang-dong), Yongin-si, KOR, 17042
Website
http://www.dtncro.com
DT&CRO Co Ltd conducts a series of consigned research, from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics and medical devices, to analysis, bioactivity, clinical trials, and licensing consulting. provided as a service.

DT&CRO Co (XKRX:383930) Headlines

No Headlines